L

LegoChem Biosciences Inc
KOSDAQ:141080

Watchlist Manager
LegoChem Biosciences Inc
KOSDAQ:141080
Watchlist
Price: 95 500 KRW -1.55% Market Closed
Market Cap: 3.5T KRW
Have any thoughts about
LegoChem Biosciences Inc?
Write Note

Intrinsic Value

The intrinsic value of one LegoChem Biosciences Inc stock under the Base Case scenario is 18 608.03 KRW. Compared to the current market price of 95 500 KRW, LegoChem Biosciences Inc is Overvalued by 81%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
18 608.03 KRW
Overvaluation 81%
Intrinsic Value
Price
L
Worst Case
Base Case
Best Case

Valuation Backtest
LegoChem Biosciences Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for LegoChem Biosciences Inc cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about LegoChem Biosciences Inc?
Bearish
Neutral
Bullish

Fundamental Analysis

Economic Moat
LegoChem Biosciences Inc

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about LegoChem Biosciences Inc

Provide an overview of the primary business activities
of LegoChem Biosciences Inc.

What unique competitive advantages
does LegoChem Biosciences Inc hold over its rivals?

What risks and challenges
does LegoChem Biosciences Inc face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for LegoChem Biosciences Inc.

Provide P/S
for LegoChem Biosciences Inc.

Provide P/E
for LegoChem Biosciences Inc.

Provide P/OCF
for LegoChem Biosciences Inc.

Provide P/FCFE
for LegoChem Biosciences Inc.

Provide P/B
for LegoChem Biosciences Inc.

Provide EV/S
for LegoChem Biosciences Inc.

Provide EV/GP
for LegoChem Biosciences Inc.

Provide EV/EBITDA
for LegoChem Biosciences Inc.

Provide EV/EBIT
for LegoChem Biosciences Inc.

Provide EV/OCF
for LegoChem Biosciences Inc.

Provide EV/FCFF
for LegoChem Biosciences Inc.

Provide EV/IC
for LegoChem Biosciences Inc.

Show me price targets
for LegoChem Biosciences Inc made by professional analysts.

What are the Revenue projections
for LegoChem Biosciences Inc?

How accurate were the past Revenue estimates
for LegoChem Biosciences Inc?

What are the Net Income projections
for LegoChem Biosciences Inc?

How accurate were the past Net Income estimates
for LegoChem Biosciences Inc?

What are the EPS projections
for LegoChem Biosciences Inc?

How accurate were the past EPS estimates
for LegoChem Biosciences Inc?

What are the EBIT projections
for LegoChem Biosciences Inc?

How accurate were the past EBIT estimates
for LegoChem Biosciences Inc?

Compare the revenue forecasts
for LegoChem Biosciences Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of LegoChem Biosciences Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of LegoChem Biosciences Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of LegoChem Biosciences Inc compared to its peers.

Compare the P/E ratios
of LegoChem Biosciences Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing LegoChem Biosciences Inc with its peers.

Analyze the financial leverage
of LegoChem Biosciences Inc compared to its main competitors.

Show all profitability ratios
for LegoChem Biosciences Inc.

Provide ROE
for LegoChem Biosciences Inc.

Provide ROA
for LegoChem Biosciences Inc.

Provide ROIC
for LegoChem Biosciences Inc.

Provide ROCE
for LegoChem Biosciences Inc.

Provide Gross Margin
for LegoChem Biosciences Inc.

Provide Operating Margin
for LegoChem Biosciences Inc.

Provide Net Margin
for LegoChem Biosciences Inc.

Provide FCF Margin
for LegoChem Biosciences Inc.

Show all solvency ratios
for LegoChem Biosciences Inc.

Provide D/E Ratio
for LegoChem Biosciences Inc.

Provide D/A Ratio
for LegoChem Biosciences Inc.

Provide Interest Coverage Ratio
for LegoChem Biosciences Inc.

Provide Altman Z-Score Ratio
for LegoChem Biosciences Inc.

Provide Quick Ratio
for LegoChem Biosciences Inc.

Provide Current Ratio
for LegoChem Biosciences Inc.

Provide Cash Ratio
for LegoChem Biosciences Inc.

What is the historical Revenue growth
over the last 5 years for LegoChem Biosciences Inc?

What is the historical Net Income growth
over the last 5 years for LegoChem Biosciences Inc?

What is the current Free Cash Flow
of LegoChem Biosciences Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for LegoChem Biosciences Inc.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
LegoChem Biosciences Inc

Current Assets 134.6B
Cash & Short-Term Investments 93.1B
Receivables 20.9B
Other Current Assets 20.6B
Non-Current Assets 54.9B
Long-Term Investments 17.3B
PP&E 25.4B
Intangibles 6.9B
Other Non-Current Assets 5.2B
Current Liabilities 37.1B
Accounts Payable 7.1B
Accrued Liabilities 11.4B
Short-Term Debt 11.8B
Other Current Liabilities 6.8B
Non-Current Liabilities 4.2B
Long-Term Debt 528.4m
Other Non-Current Liabilities 3.7B
Efficiency

Earnings Waterfall
LegoChem Biosciences Inc

Revenue
101.4B KRW
Cost of Revenue
-15.8B KRW
Gross Profit
85.6B KRW
Operating Expenses
-118.3B KRW
Operating Income
-32.7B KRW
Other Expenses
29.8B KRW
Net Income
-2.9B KRW

Free Cash Flow Analysis
LegoChem Biosciences Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

Profitability Score
Profitability Due Diligence

LegoChem Biosciences Inc's profitability score is 38/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Exceptional Revenue Growth Forecast
Exceptional 3-Years Revenue Growth
Exceptional 1-Year Revenue Growth
38/100
Profitability
Score

LegoChem Biosciences Inc's profitability score is 38/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

LegoChem Biosciences Inc's solvency score is 74/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Long-Term Solvency
Negative Net Debt
Low D/E
74/100
Solvency
Score

LegoChem Biosciences Inc's solvency score is 74/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
LegoChem Biosciences Inc

Wall Street analysts forecast LegoChem Biosciences Inc stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for LegoChem Biosciences Inc is 164 220 KRW with a low forecast of 141 400 KRW and a high forecast of 178 500 KRW.

Lowest
Price Target
141 400 KRW
48% Upside
Average
Price Target
164 220 KRW
72% Upside
Highest
Price Target
178 500 KRW
87% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for LegoChem Biosciences Inc?

Click here to dive deeper.

Dividends

LegoChem Biosciences Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for LegoChem Biosciences Inc is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

LegoChem Biosciences Inc

Country

Korea

Industry

Life Sciences Tools & Services

Market Cap

3.5T KRW

Dividend Yield

0%

Description

LegoChem Biosciences, Inc. engages in the development, manufacture of medicines, medical devices and medical supplies. The company is headquartered in Daejeon, Daejeon and currently employs 116 full-time employees. The company went IPO on 2013-05-10. The firm principally involves in the development of new drugs, including antibiotics, anticoagulants, anticancer, antiplatelet, anti-inflammatory, as well as antibody-drug-conjugates (ADC), among others. The firm operates its business through technology transfer, joint and contact research and research services.

Contact

DAEJEON
DAEJEON
10, Gukjegwahak 10-ro, Yuseong-gu
+82428610688
www.legochembio.com

IPO

2013-05-10

Employees

116

Officers

CEO, President & Director
Mr. Yong Zu Kim
CFO, COO, Vice President & Director
Mr. Sejin Park
Chief Technology Officer and Executive Vice President
Mr. Yeong Soo Oh
Chief Business Development Officer
Mr. Jeiwook Chae
Chief Development Officer & Head Researcher & Development
Dr. Young-Lag Cho Ph.D.
Head of ADC Center
Dr. Chul-Woong Chung

See Also

Discover More
What is the Intrinsic Value of one LegoChem Biosciences Inc stock?

The intrinsic value of one LegoChem Biosciences Inc stock under the Base Case scenario is 18 608.03 KRW.

Is LegoChem Biosciences Inc stock undervalued or overvalued?

Compared to the current market price of 95 500 KRW, LegoChem Biosciences Inc is Overvalued by 81%.

Back to Top